Oct. 14, 2025
| Today’s news and insights for medtech leaders
CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such as cardiovascular and robotics.
|
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
|
UPDATED
“HHS employees across multiple divisions have received reduction-in-force notices,” an administration spokesperson confirmed. It’s a significant escalation of normal shutdown procedures.
|
The 100% duties will begin Nov. 1 and stack on existing levies, the president said Friday, seemingly squashing a months-long trade truce.
|
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
|
After acquiring Paragon 28 earlier this year, Zimmer intends to maintain the foot and ankle specialist’s double-digit growth.
|
|
Device comfort and performance hinge on one critical component: the right wearable adhesive. Learn how early wear studies can differentiate your device and boost market success in this webinar.
|
|
From Our Library
Webinar - on demand
Custom content for Avery Dennison
|
Playbook
Custom content for Werner
|
Trendline
Supported by UFP Technologies Inc.
|
Playbook
Custom content for McKesson
|
| 
